Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Candesartan cilexetil
Drug ID BADD_D00347
Description Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is administered orally as the prodrug, candesartan cilexetil, which is rapidly converted to its active metabolite, candesartan, during absorption in the gastrointestinal tract. Candesartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Candesartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease.
Indications and Usage Mendis B, Page SR: Candesartan: widening indications for this angiotensin II receptor blocker? Expert Opin Pharmacother. 2009 Aug;10(12):1995-2007. doi: 10.1517/14656560903092197.
Marketing Status Prescription; Discontinued
ATC Code C09CA06
DrugBank ID DB00796
KEGG ID D00626
MeSH ID C077793
PubChem ID 2540
TTD Drug ID Not Available
NDC Product Code 62559-640; 0378-3224; 62559-643; 62332-341; 49884-659; 0378-3225; 72761-002; 49884-660; 62559-641; 63629-2127; 46708-342; 49884-661; 0378-3232; 68382-191; 70771-1204; 63629-2126; 17228-0032; 62332-342; 70518-2719; 0378-3231; 60687-119; 62332-343; 46708-060; 70771-1207; 60687-241; 70771-1205; 68382-190; 17228-0017; 46708-343; 68382-192; 62559-642; 68382-193; 49884-658; 62332-060; 46708-877; 70771-1206; 17228-0016; 17228-0018; 70518-2884; 64220-114; 60687-130; 46708-341; 52562-100; 65372-1128
Synonyms candesartan cilexetil | 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate | 1H-benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)- | Parapres | Kenzen | Amias | Blopress | Atacand | TCV 116 | TCV-116
Chemical Information
Molecular Formula C33H34N6O6
CAS Registry Number 145040-37-5
SMILES CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC 6
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardiac arrest02.03.04.001--
Cardiac failure02.05.01.0010.004525%
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.003520%Not Available
Cardiovascular disorder24.03.02.009; 02.01.01.001--Not Available
Cataract06.06.01.0010.003855%
Cerebellar syndrome17.02.02.0020.009637%Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.0030.003017%Not Available
Cerebral infarction17.08.01.004; 24.04.06.0020.005782%Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest discomfort22.02.08.001; 08.01.08.019; 02.02.02.0090.009637%Not Available
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.0010.019274%
Cholangiocarcinoma16.07.01.002; 09.04.02.0090.009637%Not Available
Cholelithiasis09.03.01.0020.009637%Not Available
Cholestasis09.01.01.0010.009637%Not Available
Chromaturia20.02.01.0020.003855%
Circulatory collapse24.06.02.0010.003855%Not Available
Coagulopathy01.01.02.001--Not Available
Cold sweat08.01.03.024; 23.02.03.0020.005782%Not Available
Colitis07.08.01.0010.007710%
Colon cancer16.13.01.001; 07.21.01.0010.001508%Not Available
Coma17.02.09.0010.007710%Not Available
Completed suicide19.12.01.001; 08.04.01.0100.002011%Not Available
Confusional state19.13.01.001; 17.02.03.0050.030838%
Congenital cystic kidney disease20.01.04.006; 16.27.01.002; 03.06.01.0030.002011%Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Coronary artery disease24.04.04.006; 02.02.01.001--Not Available
Cough22.02.03.0010.026984%
Creatinine renal clearance decreased13.13.01.0130.003855%Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 15 Pages